IPO and initial portfolio
The company was spun out through a A$9m IPO and admitted to ASX in May 2021; its first accounts cover a short post-incorporation period.
LE Minerals moved from IPO-funded exploration to a large Solaroz cash receipt. At June 2025, however, the sale was only partly completed: higher cash came with a substantial consideration liability, not a recognised sale profit.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Cash and cash equivalents at 30 June 2025.
Net cash inflow, dominated by Solaroz Tranche 1 receipts.
Consolidated total assets.
Consolidated total equity.
The review starts with a short first reporting period following incorporation in January 2021 and the May IPO. Early financial movements consequently include establishment funding and exploration expenditure rather than operating mine revenue.
The FY2025 numbers need a transaction boundary. Solaroz was still controlled at 30 June 2025, while the first tranche of its sale had completed and the remaining tranche was pending; the consideration was recorded as a liability pending completion. This explains why the balance sheet and investing cash flow cannot be read as ordinary operating performance.
The company was spun out through a A$9m IPO and admitted to ASX in May 2021; its first accounts cover a short post-incorporation period.
The FY2022 report describes Solaroz geophysics and a planned drilling programme; it also records that TEM survey data collection was completed in September 2022, after the 30 June 2022 balance date. Operating cash use for FY2022 was A$1.416m.
September and June placements supported exploration. Early exercise of the Solaroz concession option secured a disclosed discount to the remaining option price.
The 90% Solaroz sale agreement was conditional. The group reported A$24.960m assets held for sale and A$0.126m associated liabilities, rather than completed-sale income.
A 39.9% Solaroz interest was disposed of in April 2025; A$50.370m cash receipts were reported while 50.1% remained controlled pending Tranche 2.
The selected income rows are interest, foreign-exchange and other income rather than mineral sales. The FY2025 income figure is the all-segment total, while the statutory loss is separately split between continuing and discontinued operations.
Non-cash share-based payments dominated the FY2023 loss. Their subsequent fall explains much of the change in the reported result; personnel costs and foreign-exchange losses still mattered in FY2024.
The latest continuing-business cost table has a different perimeter from the earlier Group tables. The separate result bridge retains Solaroz’s discontinued loss and distinguishes translation OCI from profit or loss.
A$ million
AI-generated presentation · values from Exploration-stage income and statutory loss; no missing values plotted as zero.
A$ million
AI-generated presentation · values from FY2021–FY2024 Group cost composition; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenue and income / all-segment income | 0.038 | 0.103 | 0.515 | 0.175 | 0.739 |
| Loss after income tax / total loss for year | (1.128) | (2.305) | (12.067) | (4.824) | (6.122) |
Amounts are A$ million, consolidated statutory statements. Income is principally interest, foreign-exchange and other income; it is not mineral sales revenue.
FY2025 income is the explicitly labelled all-segment total, rather than the continuing-operations row; it is not mineral sales and it remains distinct from the FY2025 continuing/discontinued loss split below.
FY2025 OCI and comprehensive result are presented only in the separate FY2025 statutory bridge, avoiding duplicate display.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Personnel expenses | (0.174) | (0.445) | (1.183) | (2.572) |
| Share-based payments | (0.762) | (1.368) | (10.052) | (0.134) |
| Corporate expenses | (0.193) | (0.231) | (0.836) | (0.645) |
| Occupancy expenses | (0.003) | (0.043) | (0.038) | (0.086) |
| Net finance income / (expense) | (0.000225) | 0.005322 | (0.002910) | (0.079349) |
| Foreign-exchange gain / (loss) | 0.037 | 0.082 | 0.191 | (0.803) |
| Exploration and evaluation expense | 0.000 | (0.013) | (0.009) | (0.045) |
| Administration expenses | (0.036) | (0.314) | (0.461) | (0.564) |
A$ million, Group statutory scope. FY2022 finance is explicitly a net-income credit; its positive sign is retained. Finance is shown with additional decimals to preserve the small FY2021 expense.
FY2022 corporate and administration expenses use the original-year classification. The following report reallocates amounts between those two categories without changing their combined total. FY2024 also reports A$0.069m spin-out expense, separate from the recurring lines here.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Interest revenue | 0.346 |
| Personnel expenses | (1.464) |
| Share-based payments | (0.026) |
| Corporate expenses | (0.735) |
| Foreign-exchange loss | (0.956) |
| Occupancy expenses | (0.123) |
| Exploration and evaluation expenses | (0.104) |
| Finance expense | (0.004) |
| Spin-out expenses | (0.365) |
| Administration expenses | (0.371) |
A$ million, continuing operations only. This table is deliberately separate from the FY2021–FY2024 Group table.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Loss after tax — continuing operations | (3.801) |
| Loss after tax — discontinued operations | (2.320) |
| Loss for the year — total operations | (6.122) |
| Foreign-currency translation OCI | 0.148 |
| Total comprehensive income / (loss) | (5.974) |
A$ million, consolidated statutory scope. Total loss is the reported continuing-plus-discontinued result; owner-attributable loss is a different allocation and is not substituted.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Operating cash remained negative throughout. The first Solaroz tranche reversed the investing-cash direction in FY2025, whereas earlier investing had funded concession acquisition and exploration. A deposit of A$2.713m had already been received in FY2024.
Earlier financing inflows reflect the capital-raising phase, including the IPO and A$21.400m FY2023 share issues. The FY2022 dash is an explicit nil disclosure, not an unavailable value. FY2025 financing included borrowing proceeds, while a separate year-end disclosure says no borrowings; the packet does not establish a same-definition reconciliation.
The sharp FY2024 fall in the standalone exploration-asset line primarily reflects a move into held-for-sale assets, not an impairment. The bridge below keeps that reclassification separate from new expenditure. Total held-for-sale assets include more than exploration and cannot substitute for a standalone FY2025 exploration balance.
A$ million
AI-generated presentation · values from Cash flows moved from IPO funding to Solaroz transaction proceeds; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Cash flows moved from IPO funding to Solaroz transaction proceeds; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net cash used in operating activities | (0.385) | (1.416) | (3.894) | (4.614) | (5.195) |
| Net cash from / (used in) investing activities | (1.260) | (0.007) | (13.585) | (2.394) | 43.271 |
| Net cash provided by financing activities | 9.541 | 0.000 | 19.918 | 1.191 | 0.701 |
| Cash and cash equivalents at year end | 7.994 | 6.673 | 9.436 | 3.515 | 43.153 |
Negative figures are cash outflows. FY2022 financing is an explicit issuer-reported dash and is selected as a documented nil claim cell rather than inferred from a blank.
FY2025 investing cash inflow is specifically described in the saved extraction as driven by Solaroz S.A. Tranche 1 sale proceeds; it is not operating revenue.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Gross share-issue cash proceeds | 10.232 | 0.000 | 21.400 | 1.200 |
| Share-issue cash costs | (0.691) | 0.000 | (1.482) | (0.013) |
A$ million. FY2021 includes the IPO and other share-subscription cash; gross share proceeds are not identical to the A$9m IPO alone. FY2024 broker option exercises provided cash, unlike the separately disclosed cashless executive exercises.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Proceeds from borrowings | 0.051 | 1.066 |
| Axon Graphite IPO cash costs | (0.047) | (0.365) |
A$ million, financing cash flow. Borrowing proceeds are flows during the year, not an assertion of debt outstanding at year end.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Payments for exploration and evaluation in operating activities | (0.012) | (0.308) | (0.009) | (0.045) | (0.104) |
A$ million, annual cash flows. This classification is distinct from the investing-activity exploration cash table and is not aggregated with it.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Exploration and evaluation carrying value | 7.012 | 7.307 | 21.252 | 3.806 |
A$ million, 30 June asset stocks. The packet does not provide a standalone FY2025 exploration-and-evaluation balance; A$24.787m total held-for-sale assets is not substituted for it.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Investing cash payments for exploration and evaluation | (7.721) | (5.303) | (2.591) |
| Cash payment for acquisition of tenements | (5.994) | (0.010) | (0.100) |
A$ million, annual cash flows. FY2021–FY2022 exploration payments are classified in operating activities, so they are not forced into this investing-basis table.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2024 |
|---|---|
| Opening exploration and evaluation carrying value | 21.252 |
| Exploration expenditure incurred | 6.042 |
| Tenement acquisition | 0.010 |
| Reclassification to held for sale | (23.497) |
| Closing exploration and evaluation carrying value | 3.806 |
A$ million. The reclassification is presentation associated with held-for-sale accounting, not an impairment write-off.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Cash and assets rose alongside the consideration liability because Solaroz remained controlled. Tax paid on the first tranche was carried as a deferred tax asset pending the next tranche. Neither the cash receipt nor the liability is presented as a realised sale profit.
LEL securities were suspended during FY2025 after ASX determined that the company did not have a sufficient level of operations for continued quotation. This is included as an issuer-reported corporate-status fact, not a view on future reinstatement or value.
MDCo was acquired on 24 September 2025 for A$2m cash. This is a subsequent event, not FY2025 cash flow or a 30 June balance-sheet component.
A$ million
AI-generated presentation · values from Financial position: exploration assets then disposal-related balances; no missing values plotted as zero.
A$ million
| Metric | FY2025 |
|---|---|
| Tranche 1 sale cash receipts | 50.370 |
| Tax paid relating to Tranche 1 | (4.722) |
| Related deferred tax asset pending Tranche 2 — balance | 4.722 |
| Investing exploration cash payments | (2.591) |
| Net cash provided by investing activities | 43.271 |
| Tranche 1 consideration liability pending Tranche 2 | 53.171 |
| Assets classified as held for sale | 24.787 |
A$ million. Cash-flow rows are FY2025 flows; liability and held-for-sale rows are 30 June stocks.
A$50.370m cash receipts and A$53.171m consideration liability are different disclosed cash and accounting measures; neither is a recognised sale-profit measure and no reconciliation is inferred.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 15.192 | 14.253 | 33.320 | 32.548 | 78.417 |
| Total liabilities | 0.188 | 0.167 | 1.196 | 3.228 | 55.045 |
| Total equity | 15.005 | 14.086 | 32.124 | 29.320 | 23.372 |
Amounts are consolidated totals in A$ million from the selected financial-statement records.
The FY2025 asset and liability step-up follows the partly completed Solaroz transaction: the extraction records consideration as a liability pending the second tranche and continues to consolidate Solaroz at 30 June 2025.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.